Author's posts
Drug Pricing Policy Means Deciding When To Say “No”
Today, the Senate Finance Committee holds hearings to markup its ambitious drug pricing overhaul package.
Understanding this package requires thinking about the tradeoffs between low prices today, access to existing drugs today, and the development o…
What Martha’s Vineyard’s Gas Stations Can Teach Us About Drug Pricing
Price transparency can provide the tools for tacit collusion resulting in higher rather than lower prices.
It’s Time As Academics We Realize That Some Studies Should Not Be Written
Academics must realize that studies based on correlations or incomplete data that will be misinterpreted by the media are best left unwritten.
Making Markets Work For Pharmaceuticals
Markets can work for pharmaceuticals but they require the support of firms and regulators. Firms can either work to make pharmaceutical markets more competitive or accept single payer healthcare.
